Raymond Pratt
Technik-/Wissenschafts-/F&E-Leiter bei SAVARA INC.
Vermögen: 712 000 $ am 30.04.2024
Profil
Raymond D.
Pratt is an Independent Director at XORTX Therapeutics, Inc. and the Chief Medical Officer at Savara, Inc. He previously worked as the Assistant Chief & Director-Dialysis Services at Walter Reed Army Medical Center, Senior Director-Clinical Research & Development at Eisai Medical Research, Inc., Vice President-Strategic Drug Development at Quintiles Transnational Corp., Chief Development Officer at Rockwell Medical, Inc., Vice President-Research & Development at Shire Plc and Shire Pharmaceutical Development, Inc., and Assistant Professor at Weill Cornell Medical College and The Johns Hopkins University School of Medicine.
Pratt holds a doctorate degree from the University of Illinois College of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SAVARA, INC.
0,12% | 14.12.2023 | 160 000 ( 0,12% ) | 712 000 $ | 30.04.2024 |
XORTX THERAPEUTICS, INC.
-.--% | 04.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Raymond Pratt
| Unternehmen | Position | Beginn |
|---|---|---|
| XORTX THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 20.12.2021 |
| SAVARA INC. | Technik-/Wissenschafts-/F&E-Leiter | 10.11.2022 |
Ehemalige bekannte Positionen von Raymond Pratt
| Unternehmen | Position | Ende |
|---|---|---|
| ROCKWELL MEDICAL, INC. | Technik-/Wissenschafts-/F&E-Leiter | 20.11.2019 |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01.01.2012 |
| SHIRE | Geschäftsführer | 01.01.2010 |
Shire Pharmaceutical Development, Inc.
 Shire Pharmaceutical Development, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceutical Development, Inc. engages in research and development of pharmaceutical drugs. It develops drugs for the treatment of metachromatic leukodystrophy, hereditary angioedema, hunter syndrome, and gaucher diseases. The company was founded in 2000 and is headquartered in Rockville. MD. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 |
| Eisai Medical Research, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 |
Ausbildung von Raymond Pratt
| University of Illinois College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ROCKWELL MEDICAL, INC. | Health Technology |
| SAVARA INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Commercial Services |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Walter Reed Army Medical Center | |
| Eisai Medical Research, Inc. | |
Shire Pharmaceutical Development, Inc.
Shire Pharmaceutical Development, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceutical Development, Inc. engages in research and development of pharmaceutical drugs. It develops drugs for the treatment of metachromatic leukodystrophy, hereditary angioedema, hunter syndrome, and gaucher diseases. The company was founded in 2000 and is headquartered in Rockville. MD. | Health Technology |
| XORTX Therapeutics, Inc. |
